ID

19904

Descrizione

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS.

Keywords

versioni (1)
  1. 30/01/17 30/01/17 -
Caricato su

30 gennaio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

Inglese

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

1 moduli  
Telephone Visit
Descrizione

Telephone Visit

Alias
UMLS CUI-1
C0178941
contact not made
Descrizione

contact not made

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1705415
date of contact
Descrizione

date of contact

Tipo di dati

date

Alias
UMLS CUI [1]
C0805839
Person contacted
Descrizione

person contacted

Tipo di dati

text

Alias
UMLS CUI [1]
C0337611
If other, specify:
Descrizione

other person contacted

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0337611
UMLS CUI [1,2]
C3146298
Since the subject was last contacted, has the subject experienced any new or continuing adverse events? (If Yes, please record adverse event(s) in the CRF)
Descrizione

adverse event

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248
Since the subject was last contacted, has the subject received any concomitant medications? (Includes IV steroid therapy and alternate MS therapy. If Yes, please record concomitant medications in the CRF)
Descrizione

concomitant medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
Ritorna all'inizio della pagina

Similar models

Telephone Visit CRFs Multiple Sclerosis Tysabri NCT00027300

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Telephone Visit
C0178941 (UMLS CUI-1)
contact not made
Item
contact not made
boolean
C1705415 (UMLS CUI [1])
date of contact
Item
date of contact
date
C0805839 (UMLS CUI [1])
Item
Person contacted
text
C0337611 (UMLS CUI [1])
person contacted
Code List
Person contacted
CL Item
Subject (Subject)
CL Item
Other (Other)
other person contacted
Item
If other, specify:
text
C0337611 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
adverse event
Item
Since the subject was last contacted, has the subject experienced any new or continuing adverse events? (If Yes, please record adverse event(s) in the CRF)
boolean
C0877248 (UMLS CUI [1])
concomitant medication
Item
Since the subject was last contacted, has the subject received any concomitant medications? (Includes IV steroid therapy and alternate MS therapy. If Yes, please record concomitant medications in the CRF)
boolean
C2347852 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial